- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Armstrong Henry H Associates Inc. Reduces Johnson & Johnson Holdings
Institutional investor sells 7,014 shares of healthcare giant in Q4 2025
Mar. 22, 2026 at 7:23am
Got story updates? Submit your updates here. ›
Armstrong Henry H Associates Inc., an institutional investor, reduced its holdings in Johnson & Johnson (NYSE: JNJ) by 2.1% in the fourth quarter of 2025, according to a recent SEC filing. The firm now owns 320,797 shares of the company's stock, valued at $66,389,000, making it the 4th largest position in its portfolio.
Why it matters
Johnson & Johnson is a bellwether stock in the healthcare sector, and changes in institutional ownership can signal broader market trends or shifts in investor sentiment. This reduction, while relatively small, could indicate some institutional investors are taking a more cautious stance on the stock.
The details
Armstrong Henry H Associates Inc. sold 7,014 shares of Johnson & Johnson stock during the fourth quarter, reducing its total position to 320,797 shares. The firm cited unspecified portfolio rebalancing as the reason for the sale. Johnson & Johnson accounts for approximately 6.2% of Armstrong Henry H Associates Inc.'s total holdings.
- The sale occurred in the fourth quarter of 2025.
The players
Armstrong Henry H Associates Inc.
An institutional investment firm that manages a portfolio of stocks, including a sizable position in healthcare giant Johnson & Johnson.
Johnson & Johnson
A multinational healthcare company that develops, manufactures, and markets a broad range of pharmaceutical, medical device, and consumer health products.
The takeaway
This reduction in holdings by a major institutional investor highlights the ongoing scrutiny and shifting sentiment around healthcare stocks like Johnson & Johnson, as investors navigate an evolving regulatory and market landscape.
